Eribulin in soft-tissue sarcoma

Lancet. 2016 Apr 16;387(10028):1594-6. doi: 10.1016/S0140-6736(16)00162-8. Epub 2016 Feb 10.

Authors

Robin J Young¹, Penella J Woll²

Affiliations

¹ Academic Unit of Clinical Oncology, Weston Park Hospital, Sheffield S10 2SJ, UK. Electronic address: [email protected].
² Academic Unit of Clinical Oncology, Weston Park Hospital, Sheffield S10 2SJ, UK.

PMID: 26874886
DOI: 10.1016/S0140-6736(16)00162-8

No abstract available

Publication types

Comment

MeSH terms

Antineoplastic Agents / therapeutic use*
Dacarbazine / therapeutic use*
Female
Furans / therapeutic use*
Humans
Ketones / therapeutic use*
Leiomyosarcoma / drug therapy*
Liposarcoma / drug therapy*
Male
Soft Tissue Neoplasms / drug therapy*

Substances

Antineoplastic Agents
Furans
Ketones
Dacarbazine
eribulin